Ignite Creation Date:
2024-05-06 @ 2:37 PM
Last Modification Date:
2024-10-26 @ 1:34 PM
Study NCT ID:
NCT04375046
Status:
UNKNOWN
Last Update Posted:
2021-06-09
First Post:
2020-05-01
Brief Title:
Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2
Sponsor:
Organization:
Kafrelsheikh University